Contemporary, Challenging and Controversial Issues in Pulmonary Hypertension Diagnosis and Management: Web Activity

Release date: February 28, 2013
Expiration date: February 28, 2014
Estimated time to complete activity: 0.75 hour
Course viewing requirements:
PC: Internet Explorer (v6 or greater), Google Chrome, or Firefox
MAC: Safari or Firefox

                         
Jointly sponsored by Postgraduate Institute for Medicine (www.pimed.com) and Medtelligence(TM)


This program is supported by an independent educational grant from Gilead Sciences Medical Affairs

Program Overview
This online activity is based on Contemporary, Challenging and Controversial Issues in Pulmonary Hypertension Diagnosis and Management: A Saturday Morning Report(TM) CME Program held on January 12, 2013. The selected faculty presentation (audio and slides) includes a real-world, case-based review of challenging clinical presentations and management strategies for patients with suspected and diagnosed pulmonary hypertension.

Educational Objectives
After completing this activity, the participant should be better able to:

Target Audience
This activity has been designed to meet the educational needs of Pulmonologists, Clinical Cardiologists, Internists, Rheumatologists, Critical Care Specialists, Allied Health Professionals, and other healthcare professionals involved in managing patients with pulmonary arterial hypertension.

Faculty
Steven D. Nathan, MD
Dr. Nathan is Medical Director of the Advanced Lung Disease & Transplant Program at Inova Fairfax Hospital in Falls Church, Virginia. He is also Professor of Medicine at Virginia Commonwealth University. Dr. Nathan earned his medical degree from University of Witwatersrand Medical School [South Africa]. He completed his internship in internal medicine and general surgery at Johannesburg Hospital and his internal medicine residency at Long Island Jewish Hospital. His fellowships in pulmonary medicine, critical care and lung transplantation were completed at Cedars-Sinai Medical Center. Dr. Nathan has published more than 240 professional works, including original research manuscripts, abstracts, reviews and book chapters. He also has a grant from the National Institutes of Health for an ongoing collaborative NIH-Inova advanced lung disease program. His professional associations include the American Thoracic Society, from which he received the 2011 Outstanding Clinician Award for the Metropolitan DC chapter. He also belongs to the International Society for Heart and Lung Transplantation. Dr. Nathan is a frequent presenter at national and international conferences.

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Medtelligence, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Steven D. Nathan, MD: Consulting Fees, Fees for Non-CME/CE Services, and Contracted Research: Actelion Pharmaceuticals US, Inc., Gilead, United Therapeutics Corporation

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC; Trace Hutchison, PharmD; Samantha Mattiucci, PharmD; Jan Schultz, RN, MSN, CCMEP; and Patricia Staples, MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Medtelligence, LLC: Ben Caref, PhD; Pamela Clark - No financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Method of Participation and Request for Credit
There are no fees for participating and receiving CME credit for this activity. During the period February 28, 2103 through February 28, 2014, participants must read the learning objectives and faculty disclosures and study the educational activity. 

PIM supports Green CME by offering your Request for Credit online. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 9397. Upon registering and successfully completing the post-test with a score of 75% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Media
Internet

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Online Activity